By Editor , 11 September 2026
Cogent Communications Hit With Securities Suit Over Wavelength Backlog

San Francisco – September 10, 2026 -- Hagens Berman Sobol Shapiro LLP has filed a securities class action against Cogent Communications Holdings (NASDAQ: CCOI), alleging the company misrepresented its optical wavelength "backlog" as a reliable indicator of revenue growth between February 29, 2024 and May 1, 2026.

By Editor , 11 September 2026
Wix Faces Securities Suit After AI Costs Erase $1.1B in Market Value

San Francisco – September 10, 2026 -- Wix.com Ltd. (NASDAQ: WIX) is now the target of a securities class action following a 27% plunge in its share price after the company disclosed Q1 2026 results showing operating expenses had spiked 46% year-over-year. The case, Yappi v. Wix.com Ltd., et al., No. 26-cv-08852, was filed in the U.S. District Court for the Northern District of Illinois and seeks to represent investors who bought Wix securities between February 19, 2025 and May 12, 2026.

By Editor , 11 September 2026
Capricor Investors Face Sept. 28 Deadline as FDA Delays Deramiocel Ruling

San Francisco – September 10, 2026 -- Investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) have until September 28, 2026, to seek lead plaintiff status in a securities class action tied to the company's Duchenne muscular dystrophy therapy, deramiocel, as the FDA extends its review timeline.

By Editor , 11 September 2026
Pentair Securities Fraud Suit Expands Class Period to March 2025

SAN FRANCISCO – September 10, 2026 -- Hagens Berman Sobol Shapiro LLP has expanded a securities fraud class action against Pentair plc (NYSE: PNR), extending the class period back to March 11, 2025, from the original start date of April 28, 2026. The lead plaintiff deadline is set for October 2, 2026, giving investors who purchased Pentair stock during the newly expanded window until that date to seek appointment as lead plaintiff.

By Editor , 11 September 2026
DNOW Faces Securities Suit Over MRC Global ERP Failures Before Merger

San Francisco – September 10, 2026 -- DNOW Inc. (NYSE: DNOW) shares plunged 19% in a single session after the company disclosed that persistent ERP failures at newly acquired MRC Global Inc. had crushed revenues, triggering a securities class action lawsuit filed by Hagens Berman.

The suit centers on proxy materials tied to DNOW's merger with MRC Global, alleging management misrepresented the readiness of MRC's enterprise resource planning system ahead of a shareholder vote.

By Editor , 11 September 2026

Bensalem, Pa. – September 10, 2026 -- The Law Offices of Howard G. Smith has opened a lead plaintiff window until October 2, 2026, for investors who lost money on Pentair plc (NYSE: PNR) shares amid an active securities fraud class action lawsuit.

By Editor , 11 September 2026
Papa John's Hit With Securities Class Action Over Turnaround Claims

New York – September 10, 2026 -- Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Papa John's International, Inc. (NASDAQ: PZZA) and certain company officers, alleging violations of federal securities laws.

Lawsuit covers investors who bought PZZA shares over a one-year window

The class period spans August 7, 2025 to August 5, 2026. The complaint targets all persons and entities that purchased or otherwise acquired Papa John's securities during that stretch.

By Editor , 10 September 2026
XTI Aerospace Faces Securities Fraud Suit Over Disclosure Failures

Los Angeles – September 10, 2026 -- Glancy Prongay Wolke & Rotter LLP has opened a lead plaintiff window closing October 27, 2026 for investors who lost money on XTI Aerospace, Inc. securities amid allegations of securities fraud.

Class period spans four months of allegedly misleading statements

The complaint covers purchases made between April 15, 2026 and August 17, 2026, during which defendants allegedly made materially false or misleading statements about XTI Aerospace's business, operations, and prospects.

By Editor , 10 September 2026
Beta Bionics Faces Class Action Over iLet Insulin Pump Disclosures

San Diego – September 10, 2026 -- Robbins LLP has filed a securities class action against Beta Bionics, Inc. (NASDAQ: BBNX) on behalf of investors who purchased common stock between July 30, 2025 and February 24, 2026, alleging the company misrepresented the safety and commercial viability of its iLet Bionic Pancreas insulin pump.